Cordovez Jose A, Traboulsi Elias I, Capasso Jenina E, Sadagopan Karthikeyan Arcot, Ganesh Anuradha, Rychwalski Paul J, Neely Kimberly A, Brodie Scott E, Levin Alex V
a Ocular Genetics, Wills Eye Institute , Philadelphia , PA , USA .
Ophthalmic Genet. 2015;36(3):257-64. doi: 10.3109/13816810.2014.881505.
To report the occurrence of intraretinal cystoid spaces presumably due to retinal degeneration caused by CRB1 mutations, and the response to treatment with carbonic anhydrase inhibitors.
Retrospective case series.
We report four patients with retinal degeneration and intraretinal cystoid spaces due to CRB1 mutation. Of these patients, three were treated with topical carbonic anhydrase inhibitors. One of these three patients was changed to oral carbonic anhydrase inhibitor. Best corrected visual acuity and quantitative and qualitative macular optical coherence tomography results were recorded.
Three patients were compound heterozygous for CRB1 mutations, and one had two mutations one of which was not found in the father. A total of seven different mutations were detected. All patients treated with carbonic anhydrase inhibitors experienced an improvement in visual acuity and decreased central retinal thickness, except in one eye in which retinal thickness paradoxically increased.
CRB1 mutations may be associated with intraretinal cystoid spaces. The use of carbonic anhydrase inhibitors can result in improved visual acuity in some patients.
报告推测由CRB1突变引起的视网膜变性导致的视网膜内囊样间隙的发生情况,以及碳酸酐酶抑制剂的治疗反应。
回顾性病例系列。
我们报告了4例因CRB1突变导致视网膜变性和视网膜内囊样间隙的患者。其中3例患者接受了局部碳酸酐酶抑制剂治疗。这3例患者中有1例改为口服碳酸酐酶抑制剂。记录最佳矫正视力以及黄斑区定量和定性光学相干断层扫描结果。
3例患者为CRB1突变的复合杂合子,1例有两个突变,其中一个在其父亲中未发现。共检测到7种不同的突变。所有接受碳酸酐酶抑制剂治疗的患者视力均有改善,视网膜中央厚度降低,但有一只眼视网膜厚度反而增加。
CRB1突变可能与视网膜内囊样间隙有关。使用碳酸酐酶抑制剂可使部分患者视力提高。